|
Drug |
Indications |
Dose |
Route |
Frequency |
|
Acarbose |
Hyperglycaemia |
12.5 - 20 mg |
Oral |
with each meal |
|
Acemannan (Aloe vera derivative) |
Immunomodulation |
1-2 mg/kg |
Intralesional, IP or SQ |
weekly |
|
Acepromazine
(ACP) |
Sedation, restraint |
0.05-2.25 mg/kg |
SQ, IM, PO |
q 8-12hrs |
|
Arterial thromboembolism |
0.15-0.3 mg/kg |
SQ |
q 8-12hrs |
|
Amphetamine toxicosis |
0.05 -1.0 mg/kg |
IV, IM, SQ |
q 8-12hrs |
|
Acetazolamide |
Glaucoma |
5-10 mg/kg |
PO |
q 8-12hrs |
|
Acetylcysteine |
Mucolytic and acetaminophen toxicity |
140 mg/kg |
IV |
loading dose |
|
|
70 mg/kg |
PO |
4-6 x 5-7 treatments |
|
Acetylsalicylic acid (Aspirin) |
Antipyretic |
6-10 mg/kg |
PO |
q 48 - 72hrs |
|
Antithrombotic |
80 mg/cat or 25 mg/kg |
PO |
2 times/wk |
|
Anti-inflammatory |
10-20 mg/kg |
PO |
q 48 hrs |
|
Analgesia |
10 mg/kg |
PO |
q 48hrs |
|
Actinomycin-D |
Anticancer / antimicrobial |
0.5-0.9 mg/m2 |
IV |
once every 3 weeks |
|
Acyclovir |
Anti-herpes viral |
200 mg |
PO |
q 6hrs |
|
S-Adenosylmethionine (SAME) |
Replenishes glutathione stores in chronic liver disease |
20-30 mg/kg |
PO |
q 24hrs |
|
Albendazole |
Lung worm |
50 mg/kg |
PO |
daily for 21 days |
|
Albuterol (Salbutamol) |
Bronchodilation |
|
PO |
q 6 - 8hrs |
|
Allopurinol |
Urate urolithiasis |
10 mg/kg |
PO |
q 8 - 12hrs for 30 days |
|
Alprazolam (Benzodiazepine) |
Elimination
behavioural problems |
0.125-0.25 mg/cat |
PO |
q 12hrs |
| Aluminium carbonate gel |
Phosphate binder |
10-30 mg/kg |
PO with meals |
q 8hrs |
| Aluminium hydroxide |
Antacid |
20-30 ml |
PO |
q 2 - 4hrs |
|
Phosphate binder |
30-90 mg/kg |
PO with meals |
q 8 - 24hrs |
|
Amantadine |
Analgesia for chronic pain |
3-5 mg/kg |
PO |
daily for 7-14 days |
|
Amikacin |
Susceptible infections |
15-22 mg/kg |
IM, IV, SQ |
q 24hrs |
|
Aminopentamide (Centrine) |
Antidiarrheal |
0.1 mg/cat |
SC, IM, PO |
q 8 - 12hrs |
|
Aminophylline |
Bronchodilator |
4-6.6 mg/kg |
PO |
q 8 - 12hrs |
|
|
2-5 mg/kg |
IV infusion |
q 12hrs |
| Aminopromazine |
Smooth muscle relaxant |
2.0-4.5 mg/kg |
PO |
q 12hrs |
| 6-aminosalicylic acid |
Irritable bowel syndrome |
see mesalamine, olsalazine |
|
|
|
Amitriptyline
(Endep-10) |
Behaviour, urine spraying |
2 mg/kg or 5-10 mg/cat |
PO |
q 24hrs |
|
Amlodipine besylate
(Norvasc) |
Systemic hypertension |
0.625 mg/cat |
PO |
q 24hrs |
| Ammonium chloride |
Struvite dissolution |
800 mg/cat |
PO |
q 24hrs |
|
Amoxicillin/clavulanic
acid |
Susceptible infections |
10-20 mg/kg |
PO |
q 12hrs |
|
Amoxil
(Amoxicillin) |
Susceptible
infections |
4-11 mg/kg |
PO |
q 12hrs |
|
Amphetamine sulphate |
CNS stimulation during certain toxicoses |
5 mg/cat |
PO |
q 12hrs |
|
Amphotericin B |
Systemic mycoses |
0.15-1 mg/kg in 5% dextrose |
IV |
q 48hrs to a total cumulative dose of
10mg/kg |
|
|
|
SQ |
diluted 1:10 in saline |
|
Ampicillin |
Susceptible infections |
20-60 mg/kg |
PO |
q 8 - 12hrs |
|
Amprolium |
Coccidiosis |
60-100 mg/kg |
PO |
q 24hrs x 5 d |
|
With sulfadimethoxine |
150 mg/kg |
PO |
q 24hrs x 5d |
| Aprotonin |
Protease inhibitor (pancreatitis), fibrinolytic agent |
5000 KUI (kallikrein inhibitor units)/kg |
IP |
q 6 - 8hrs |
| Ascorbic acid (Vitamin C) |
Feline infectious peritonitis |
25-125 mg/kg/day |
PO |
q 24hrs |
|
Acetaminophen toxicosis |
30 mg/kg |
PO, SQ |
6x7 treatments |
|
Asparaginase |
Lymphosarcoma |
10,000 U/m2 |
IV |
weekly as part of a protocol |
|
Atenolol (Tenormin) |
ß1-blocker for
HCM + hypertension |
6.25 mg/cat |
PO |
q 24hrs |
|
Atipamezole (Antisedan) |
Medetomidine reversal |
equivolume |
IM |
as needed |
|
Atovaquone |
Antiprotozoal (pneumocystosis) |
13.3 mg/kg with fatty meal |
PO |
q 8hrs x 21 days |
|
Atracurium
besylate |
Paralytic
anaesthetic agent |
0.1-0.25 mg/kg |
IV |
repeated q 30mins |
|
Atropine |
Sinus
bradycardia |
0.02-0.04 mg/kg |
IM, IV, SQ |
as required |
|
Organophosphate
toxicity |
0.2-2.0 mg/kg |
IM, SQ |
q 2hrs |
|
Aurothioglucose |
Pemphigus complex,
LPS, and podomatitis |
2 mg |
IM |
stat, then 1 mg/kg weekly |
|
Azathioprine |
Enteritis |
0.2-0.3 mg/kg |
PO |
q 24-48hrs |
|
Immune haemolytic anaemia
|
1 mg/kg |
PO |
q 24-48hrs |
|
Immunosuppression |
1.1 mg/kg |
PO |
q 48hrs |
|
Azithromycin (Zithromax) |
Susceptible
infections |
5 mg/kg |
PO |
q 24 - 48hrs |
|
Susceptible
infections |
80 mg stat |
PO |
weekly x 3 |
|
Aztreonam |
Susceptible
infections |
12-25 mg/kg |
IV, IM |
q 8-12hrs |
|
Baquiloprim |
Coccidiosis |
30 mg/kg |
PO |
q 48hrs x 2 |
|
Baytril |
Susceptible
infections |
5.0-20.0 mg/kg |
PO, SQ, IM, IV
(with caution - may cause blindness) |
q 24hrsfor
7-10 days |
|
Beclomethasone dipropionate
|
Anti-inflammatory |
200 mg |
Inhalant |
as required |
|
Benazepril
(Fortekor) |
Afterload
reduction (Renal, CHF) |
0.25-0.5 mg/kg |
PO |
q 24hrs |
|
Benzimidazole |
Trypanosomiasis |
5 mg/kg |
PO |
q 24hrs for 4
months |
|
Benzocaine |
Local
anaesthetic |
1-5 ml |
SQ |
as required |
|
Benzoyl
peroxide |
Seborrheic,
antibacterial |
leave on skin
for 10mins |
|
q 3 - 4days for 2
weeks |
|
Betamethasone |
Anti-inflammatory |
0.1-0.2 mg/kg |
PO |
q 12 - 24hrs |
|
Bethanechol |
Bladder atony,
dysautonia |
1.25-5.0 mg |
PO |
q 8- 12hrs |
|
Bisacodyl |
Stool softener |
2-5 mg/cat |
PO |
q 24hrs as
needed |
|
Bismuth
subcarbonate |
GI tract
protectant |
0.3-3.0 gm |
PO |
q 4hrs |
|
Antidiarrheal,
antiemetic |
1-3 ml/kg |
PO |
q 4 - 6hrs |
|
Bleomycin |
Chemotherapy |
10
µg/m2 |
IV, SQ |
q 24hrs for 4
days, then weekly; max dose 200mg/m2 |
| Bran |
Stool softener |
1-2 teaspoons/400g
food |
PO |
as needed |
| Brewer's yeast |
B vitamin
source |
0.2
µg |
PO |
q 24hrs |
|
Bromide, Potassium |
Anticonvulsant |
30-60 mg/kg |
PO |
q 12hrs |
|
Bromocriptine
mesylate |
Cushing's syndrome,
false pregnancy, lactation cessation |
10-30
µg/kg |
PO |
q 24hrs for 10 -16 days |
| Bunamidine |
Taenia, Dipylidium |
20-50 mg/kg |
PO |
after 3hr fast |
|
Bupivicaine
hydrochloride |
Local
Anaesthetic |
0.22-3.0 ml/cat |
Epidural |
stat |
|
Buprenorphine |
Opioid
analgesic |
0.005-0.01 mg/kg |
IV, IM |
q 4-8hrs |
|
Buspirone
(Clomicalm) |
Behavioural
therapy |
2.5-5.0mh/cat |
PO |
q12-24hrs |
|
Busulfan |
Chronic
myelocytic leukaemia |
3-4mg/m2 or
0.1 mg/kg |
PO |
q 24hrs |
| Butamisole |
Hookworm,
whipworm |
2.2mg/kg |
SQ |
q 21days |
|
Butorphanol |
Preanaesthetic |
0.05-0.4mg/kg
with ACP |
IV, IM, SQ |
|
|
Antiemetic |
0.2-0.6mg/kg |
SQ, IM, IV |
|
|
Analgesia |
0.1-0.8 mg/kg |
PO |
q 6 - 12hrs |
|
Calcitriol |
Hypoparathyroidism,
renal secondary hyperparathyroidism |
1.5 - 3.0 ng/kg |
PO |
q 24hrs |
| Calcium
carbonate |
Nutritional
supplement |
1/2 tsp |
PO |
daily |
|
Phosphate
binder |
60-100 mg/kg |
PO |
daily |
| Calcium
chloride 10% |
Ventricular
asystole |
1 ml/9kg or
0.1-0.3ml/kg |
IV (slowly) |
stat |
|
Hypocalcaemia |
1 ml/9kg |
IV |
stat |
| Calcium
citrate |
Calcium
replacement,
urolithiasis |
10-30 mg/kg |
PO |
q 8hrs |
|
Calcium EDTA |
Lead poisoning |
100 mg/kg/day |
SQ |
daily for 5
days |
| Calcium
gluconate |
Ventricular
asystole |
0.5-1.5 ml/kg |
IV (slowly) |
as required |
|
Hypocalcaemia,
hyperkalemia |
0.5-1.5 ml/kg |
IV (slowly) |
as required |
|
Captan powder
50% |
Dermatomycoses |
2
tablespoons/gal water |
topically, do
not rinse |
2-3 x week |
|
Captopril |
Vasodilator |
2-3 mg/cat |
PO |
q 8-12hrs |
|
|
3-6.25 mg/cat |
PO |
q 12hrs |
| Carbenicillin |
Susceptible
infections |
15-30 mg/kg |
IV |
q 8hrs |
|
Carbenicillin
indanyl sodium |
Urinary tract
infections |
10-55 mg/kg |
PO |
q 8hrs |
|
Carbimazole |
Hyperthyroidism |
5 mg/cat |
PO |
q 8 - 12hrs |
|
Carboplatin |
Chemotherapy |
200 mg/m2 |
IV |
q 4weeks |
|
Carmustine |
Chemotherapy |
50 mg/m2 |
IV |
q 6weeks |
|
Carprofen (Rimadyl) |
Analgesic |
1-4 mg/kg |
SQ |
stat |
|
|
0.5-1.0 mg/kg |
PO |
q 24hrs |
|
Cefadroxil (Cefa-drops - cephalosporin) |
Susceptible
infections |
50 mg/cat |
PO |
q 24hrs
for 1-4 weeks |
|
Cephalexin (Rilexin) |
Susceptible
infections |
10-35 mg/kg |
PO |
q 8 - 12hrs |
|
Cetacaine |
Topical
anaesthetic |
Use cautiously |
Topical |
May cause methaemaglobinaemia |
| Charcoal,
activated |
Adsorbent for
poisonings |
1-8g/kg |
PO |
as needed |
|
Chlorambucil |
Chemotherapy |
0.1-0.5mg/kg |
PO |
q 48-72hrs |
|
Immune
mediated skin disease |
0.1-0.2mg/kg |
PO |
q 48hrs with
prednisolone |
|
Chloramphenicol |
Susceptible
infections |
50mg/cat |
PO |
q 12hrs |
|
Chlordiazepoxide-clidinium (Benzodiazepine) |
Irritable
bowel syndrome |
1-2 tabs |
PO |
q 12hrs |
| Chlorhexidine
0.5% |
Burns |
dilute 1:40
with saline |
topically |
q 24hrs |
|
Chlorothiazide |
Diuretic |
10-40 mg/kg |
PO |
q12hrs |
|
Partial ADH
deficiency |
20-40 mg/kg |
PO |
q12hrs |
|
Chlorpheniramine |
Antihistamine |
1-2 mg/cat |
PO |
q 8-12hrs |
|
Excessive
grooming |
2-4 mg/cat |
PO |
q 12-24hrs |
|
Antiemetic |
0.5 mg/kg |
IM |
q 6-8hrs |
|
Chlortetracycline
hydrochloride |
Susceptible
infections |
25 mg/kg |
PO |
q 6-8hrs |
|
Cholecalciferol
(Vit D) |
Hypocalcaemia |
500-2000 U/kg |
PO |
q 24hrs |
|
Cimetidine |
Esophagitis,
gastric ulceration, antiemetic, chronic gastritis |
5-15 mg/kg |
PO, IV, IM |
q 8 -12hrs |
|
Immunomodulator |
10-25 mg/kg |
IV, IM, PO |
q 12hrs |
|
Ciprofloxacin |
not
bioavailable in cats |
|
|
|
|
Cisapride
(Prepulsid) |
Chronic constipation, megacolon |
0.5-5.0mg/cat |
PO |
q 12hrs |
|
Clarithromycin |
Atypical
mycobacterial |
50 mg/cat |
PO |
q 12hrs |
|
Clavulox
(Amoxicillin / Clavulanic acid) |
Susceptible infections |
10-20 mg/kg |
PO |
q 12hrs |
|
Clindamycin |
Anaerobic
infections |
5-11 mg/kg |
PO |
q 12hrs |
|
Stomatitis,
acute pancreatitis |
22 mg/kg |
PO |
q 24hrs |
|
Pancreatic
exocrine insufficiency |
5-10 mg/kg |
PO |
q 6 - 8hrs |
|
Enteroepithelial
cycle |
12.5-50 mg/kg |
PO |
q 12hrs |
|
Clofazimine |
Feline leprosy |
4-8 mg/kg |
PO |
q 24hrs for 6
weeks |
|
|
50 ng/cat |
PO |
q 48hrs |
|
Clomipramine |
Behaviour
modification |
1-5 mg/cat |
PO |
q 12 - 24hrs |
|
Clonazepam (Benzodiazepine) |
Anticonvulsant,
behaviour therapy |
0.5 mg/kg |
PO |
q 8-12hrs |
|
Clorazepate (Benzodiazepine) |
Anxiolytic
drug |
1-2 mg/kg |
PO |
q 8 - 12hrs |
|
Clotrimazole |
Dermatophytosis |
apply to
lesion |
topical |
q 12hrs |
|
Antifungal |
60 ml of 1 g/dl
of polyethylene glycol intranasal |
|
over 1 hr
under general anaesthesia |
|
Cloxacillin |
Susceptible
infections |
20-40 mg/kg |
PO, IM, IV |
q 4 - 8hrs |
| Coal tar
shampoos |
Seborrhoea |
Keep in
contact with skin for 10 mins |
Topically |
q 24hrs |
|
Cobalamin |
see Vit B12 |
|
|
|
| Cod liver oil |
|
1 teaspoon / 10 kg |
|
|
|
Codeine |
Pain relief |
0.5-4 mg/kg |
PO |
q 6 - 12hrs |
|
Antitussive,
analgesia |
0.1-0.3 mg/kg |
PO |
q 4 - 6hrs |
|
Colchicine |
Antifibrotic |
0.01-0.3 mg/kg |
PO |
q 4 - 6hrs |
|
Colony
stimulating factor |
Neutropenia |
2.5-5.0 mg/kg |
SQ |
q 24hrs |
|
Corticotrophin
gel (ACTH) |
Response test |
pre-ACTH
sample 0.5-2.2 IU/kg |
IM |
|
| Cortisone
acetate |
Hypoadrenocorticism (
Addison's) |
1 mg/kg |
PO, IM |
q 24hrs |
| Cosequin® |
Osteoarthritis |
1 capsule |
PO |
q 24hrs |
|
Cosyntropin |
pre-ACTH
sample |
0.125 mg/cat |
IV |
|
|
|
1-2 mg/kg |
PO (with
caution) |
q 12hrs x 2 |
|
Cromolyn
sodium 4% (Cromone) |
Allergic
conjunctivitis |
|
Topically |
q 4 - 6hrs |
|
Cyanocobalamin |
Vit B12
deficiency |
50-1000
µg |
PO, IM, SQ |
q 24hrs |
|
Cyclizine |
Antiemetic |
4 mg/kg |
IM |
q 8hrs |
|
Cyclophosphamide |
Anticancer |
100 mg/m2 |
IV |
|
|
Feline mammary
cancer |
100 mg/m2 |
PO |
q 3 weeks with
doxorubicin |
|
Immune haemolytic
anaemia |
2 mg/kg (50mg/m2) |
PO |
q 24hrs for 4 days per week |
|
Lymphosarcoma,
myeloproliferative disorders |
50 mg/m2 |
PO |
q 48hrs |
|
Autoimmune
skin disease,
SLE |
50 mg/m2 |
PO |
q 24hrs 4
days/wk or q 48hrs |
|
Multiple
myeloma |
7 mg/kg |
PO |
once |
|
FIP |
2-4 mg/kg |
PO |
q 24hrs 4 days
a week |
|
Eosinophilic
enteritis |
6.6 mg/kg |
PO |
q 3days then q 24hrs |
|
|
2.2 mg/kg |
PO |
q 24hrs |
|
Immunosuppressive
therapy |
2.2 mg/kg (6.25-12.5 mg/cat) |
PO |
q 48hrs or q 24hrs for 4 days a week |
|
Cyclosporin |
Immune-mediated thrombocytopenia, SLE, sebaceous adenitis |
4-6 mg/kg |
4hr IV
infusion |
q 24hrs (avoid
extravasation) |
|
|
3-7 mg/kg |
PO |
q 12hrs |
|
|
10 mg/kg |
PO |
q 12hrs |
|
Cyclosporine
ophthalmic |
Keratoconjunctivitis sicca, pigmentary keratitis plasmoma of third eyelid |
1-2% solution |
drop in eye |
q 12hrs |
| Cyclothiazide |
Diuretic |
0.5-1.0 mg/kg |
PO |
q 24hrs |
|
Cyproheptadine |
Appetite
stimulant |
1-4 mg/cat |
PO |
q 12 - 24hrs |
|
Cytarabine |
Anticancer |
30-50 mg/kg |
IV, IM, SQ |
once a week |
|
|
100 mg/m2 |
IV. IM, SQ |
q 24hrs for 4
days then |
|
|
20 mg/m2 |
Intrathecal |
q 24hrs for 1 - 5
days |
|
Cythioate |
Tick
prevention |
1.5-3.3 mg/kg |
PO (tab) |
q 72hrs or 2 x
week |
|
|
0.22 ml/kg |
PO (liquid) |
q 72hrs or 2 x
week |
|
Dacarbazine |
Lymphoreticular
neoplasms |
200-250 mg/m2 |
IV |
q 24hrs for 5
days, every 21 days |
|
Soft tissue
sarcomas |
1000 mg/m2 |
IV infusion |
over 6 - 8hrs,
every 21 days |
|
Dactinomycin (Actinomycin-D) |
Anticancer |
0.015 mg/kg |
IV |
q 24hrs for 3 - 5
days, wait 3 weeks then |
|
|
0.7-1.5 mg/m2 |
IV |
weekly |
|
Dalteparin
(low MW heparin) |
DIC,
thrombosis |
70 IU/kg |
SQ |
q 24hrs |
| Danazolol |
Immune-mediated
disorders |
5-10 mg/kg |
PO |
q 12hrs |
|
Dapsone |
Mycobacteriosis |
1.1 mg/kg |
PO |
q 12hrs for 4-6
weeks |
|
Brown recluse
spider bite |
0.7-1.0 mg/kg |
PO |
q 8hrs |
| Decatibine
(Dacogen) |
Anticancer;
chronic
lymphocytic leukaemia (methylation inhibitor) |
400-800 mg/m2 |
IV, SQ |
q 24hrs x 10 |
|
Deferoxamine
mesylate |
Iron chelator |
10 mg/kg |
IV, IM, SQ |
q 2hrs for 2
doses then q 8hrs for 24 hrs |
|
Repertusion
(ischaemia) injuries |
50 mg/kg |
IV |
over 5 mins |
|
Demeclocycline |
Inappropriate
ADH secretion |
3-12 mg/kg |
PO |
q 6 - 12 hrs |
|
Deprenyl (Fitergol) |
Hyperadrenocorticism,
cognitive dysfunction |
see Selegiline |
|
|
| Derm caps |
Skin disorders |
1 capsule per
9kg |
PO |
q 24hrs |
|
Desmopressin
acetate |
Central
diabetes insipidus |
0.3
µg/kg |
IM |
q 12 - 24hrs |
|
Desoxycorticosterone
acetate |
Hypoadrenocorticism |
0.2-0.4 mg/kg |
conjunctivally |
q 24hrs, max
5mg |
|
Desoxycorticosterone
pivalate |
Hypoadrenocorticism |
25 mg |
IM |
stat |
| Dexamethasone |
Central
oedema, spinal cord trauma, DJD, other CNS trauma |
2 mg/kg |
IV |
then, |
|
|
1 mg/kg |
IV, SQ |
q 8-12hrs, then |
|
|
0.1 mg/kg |
IV, SQ, PO |
q 8-12hrs |
|
Hydrocephalus |
0.25 mg/kg |
IV, IM, PO |
q 6 - 8hrs |
|
Shock,
anaphylaxis |
4 - 6 mg/kg |
IV (slowly) |
|
|
Immune-mediated
disease |
0.25-1.25 mg/kg |
PO |
q 12 - 24hrs |
|
|
0.1-0.15 mg/kg |
SQ, PO |
q 12hrs for 5 - 7
days, then taper dose |
|
Adrenocorticoid
collapse |
0.1-0.5 mg/kg |
SQ, IV |
with
mineralocorticoids |
|
Feline
bronchial asthma |
1 mg/kg |
IV |
then |
|
|
0.25-1.0
mg/cat |
PO |
q 8 - 24hrs |
|
Dexrazoxane |
Iron chelation
for doxorubicin-induced cardiotoxicity |
25 mg/kg (ratio
of 10-20:1 dexrazoxane : doxorubicin) |
IV |
15 mins before
doxorubicin |
| Dextran 40 |
Shock |
10-20 ml/kg |
IV |
q 24hrs |
| Dextran 70 |
Volume
expander |
10-20 ml/kg |
IV |
q 24hrs to
effect |
|
Dextroamfetamine |
|